Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and Extravascular Hemolysis

levofloxacin has been researched along with Extravascular Hemolysis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Aung, TT; Beuerman, RW; Caroline, V; Chew, YS; Koh, JJ; Lakshminarayanan, R; Li, J; Lin, H; Liu, S; Pang, LM; Tan, AL; Tan, DT; Verma, C1
Aung, TT; Beuerman, RW; Cao, D; Koh, JJ; Lakshminarayanan, R; Lim, F; Lin, S; Liu, S; Ren, L; Sin, WLW; Tan, DTH; Wang, L; Zhou, L1
Saadh, MJ1
Gupta, S; Sukhal, S1
Capon, RJ; Ghaffar, KA; Hussein, WM; Khalil, ZG; Skwarczynski, M; Toth, I1

Other Studies

5 other study(ies) available for levofloxacin and Extravascular Hemolysis

ArticleYear
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
    Journal of medicinal chemistry, 2015, Aug-27, Volume: 58, Issue:16

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cell Membrane; Cell Survival; Drug Resistance, Bacterial; Enterobacteriaceae; Fatty Acids; Female; Fibroblasts; Gram-Negative Bacteria; Hemolysis; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Lipopeptides; Lipopolysaccharides; Male; Mice; Microbial Sensitivity Tests; Permeability; Rabbits

2015
Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA).
    Journal of medicinal chemistry, 2017, 07-27, Volume: 60, Issue:14

    Topics: Animals; Anti-Bacterial Agents; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Cell Survival; Drug Resistance, Bacterial; Fibroblasts; Flavones; Hemolysis; Humans; Keratitis; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Mimicry; Rabbits; Staphylococcus aureus; Structure-Activity Relationship

2017
Effect of silver nanoparticles on the antibacterial activity of Levofloxacin against methicillin-resistant Staphylococcus aureus.
    European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:17

    Topics: Anti-Bacterial Agents; Borohydrides; Hemolysis; Humans; Levofloxacin; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Silver Nitrate

2021
Drug-induced immune haemolytic anaemia caused by levofloxacin.
    Singapore medical journal, 2014, Volume: 55, Issue:8

    Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Autoantibodies; Female; Fluoroquinolones; Hemolysis; Humans; Immunoglobulin G; Levofloxacin; Male; Middle Aged; Steroids

2014
Levofloxacin and indolicidin for combination antimicrobial therapy.
    Current drug delivery, 2015, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell-Penetrating Peptides; Chemistry, Pharmaceutical; Drug Carriers; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Humans; Levofloxacin; Microbial Sensitivity Tests; Peptide Fragments; Solid-Phase Synthesis Techniques; tat Gene Products, Human Immunodeficiency Virus; Technology, Pharmaceutical

2015